These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26827604)

  • 21. [Pneumology. From the diagnosis of pulmonary functions to molecular medicine].
    Seeger W
    Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1566-9. PubMed ID: 10664658
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.
    Nobakht M Gh BF; Aliannejad R; Rezaei-Tavirani M; Taheri S; Oskouie AA
    Biomarkers; 2015 Feb; 20(1):5-16. PubMed ID: 25403491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Check-ups in pneumonology].
    Keller R
    Ther Umsch; 1989 Jun; 46(6):349-56. PubMed ID: 2667188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
    Sung HJ; Cho JY
    BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.
    Wu AC; Kiley JP; Noel PJ; Amur S; Burchard EG; Clancy JP; Galanter J; Inada M; Jones TK; Kropski JA; Loyd JE; Nogee LM; Raby BA; Rogers AJ; Schwartz DA; Sin DD; Spira A; Weiss ST; Young LR; Himes BE
    Am J Respir Crit Care Med; 2018 Dec; 198(12):e116-e136. PubMed ID: 30640517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications.
    Ebrahimi A; Sadroddiny E
    Pulm Pharmacol Ther; 2015 Oct; 34():55-63. PubMed ID: 26319446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of induced sputum examination in respiratory system diseases].
    Bareła-Malczewska AD; Chazan R
    Pol Merkur Lekarski; 2011 Feb; 30(176):126-31. PubMed ID: 21544983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State-of-the-Art Series on Precision Medicine in Respiratory Diseases.
    Lange C; Siddiqui S
    Respiration; 2016; 92(4):197-198. PubMed ID: 27626791
    [No Abstract]   [Full Text] [Related]  

  • 29. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic update in respiratory medicine].
    Louis R; Bosquée L; Duysinx B; Corhay JL
    Rev Med Liege; 2007; 62(5-6):288-92. PubMed ID: 17725196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD.
    Bihlet AR; Karsdal MA; Bay-Jensen AC; Read S; Kristensen JH; Sand JMB; Leeming DJ; Andersen JR; Lange P; Vestbo J
    Chest; 2015 Jul; 148(1):16-23. PubMed ID: 25856563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD).
    Rana GS; York TP; Edmiston JS; Zedler BK; Pounds JG; Adkins JN; Varnum SM; Smith RD; Liu Z; Li G; Webb BT; Murrelle EL; Flora JW
    Anal Bioanal Chem; 2010 Jul; 397(5):1809-19. PubMed ID: 20442989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating Asthma: Dissecting the Role of Metabolomics, Genomics and Personalized Medicine.
    Bush A
    Indian J Pediatr; 2018 Aug; 85(8):643-650. PubMed ID: 29185231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developments for a growing Japanese patient population: facilitating new technologies for future health care.
    Kato H; Nishimura T; Ikeda N; Yamada T; Kondo T; Saijo N; Nishio K; Fujimoto J; Nomura M; Oda Y; Lindmark B; Maniwa J; Hibino H; Unno M; Ito T; Sawa Y; Tojo H; Egawa S; Edula G; Lopez M; Wigmore M; Inase N; Yoshizawa Y; Nomura F; Marko-Varga G
    J Proteomics; 2011 May; 74(6):759-64. PubMed ID: 21184850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diseases to differentiate from COPD, with emphasis on bronchial asthma].
    Kanazawa M
    Nihon Rinsho; 2007 Apr; 65(4):675-81. PubMed ID: 17419387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine.
    Wheelock ÅM; Wheelock CE
    Mol Biosyst; 2013 Nov; 9(11):2589-96. PubMed ID: 23999822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Insights on the Impact of Proteomics in Respiratory Allergies.
    Vizuet-de-Rueda JC; Montero-Vargas JM; Galván-Morales MÁ; Porras-Gutiérrez-de-Velasco R; Teran LM
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chest Physician?
    Convery R
    Ulster Med J; 2019 Sep; 88(3):185-186. PubMed ID: 31619859
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
    Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
    J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systems Biology and Clinical Practice in Respiratory Medicine. The Twain Shall Meet.
    Thamrin C; Frey U; Kaminsky DA; Reddel HK; Seely AJ; Suki B; Sterk PJ
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1053-1061. PubMed ID: 27556336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.